 | • レポートコード：MRC2302E0154 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、252ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：化学 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートは、2021年に3,892.78百万ドルであった世界の組換えタンパク質市場規模が、2022年に4,436.22百万ドルになり、2027年まで年平均14.21%で成長して8,641.69百万ドルに達すると予測しています。本レポートでは、組換えタンパク質の世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別（接着分子＆レセプター、成長因子ケモカイン、キナーゼタンパク、膜タンパク質、その他）分析、用途別（学術研究、バイオ医薬品生産、バイオテクノロジー研究、創薬＆医薬品開発、その他）分析、エンドユーザー別（学術研究機関、バイオテクノロジー企業、受託研究機関、製薬企業＆バイオ製薬企業）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目を掲載しています。また、本書には、Abcam plc、Abnova Corporation、ACROBiosystems、Bio-Rad Laboratories, Inc.、BioLegend, Inc.、BPS Bioscience, Inc.、CellGenix GmbH、Enzo Life Sciences, Inc.、GenScript Biotech Corporation、Merck KGaA、Miltenyi Biotech Inc.、Neuromics、PeproTech, Inc.などの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の組換えタンパク質市場規模：製品別 - 接着分子＆レセプターの市場規模 - 成長因子ケモカインの市場規模 - キナーゼタンパクの市場規模 - 膜タンパク質の市場規模 - その他製品の市場規模 ・世界の組換えタンパク質市場規模：用途別 - 学術研究における市場規模 - バイオ医薬品生産における市場規模 - バイオテクノロジー研究における市場規模 - 創薬＆医薬品開発における市場規模 - その他用途における市場規模 ・世界の組換えタンパク質市場規模：エンドユーザー別 - 学術研究機関における市場規模 - バイオテクノロジー企業における市場規模 - 受託研究機関における市場規模 - 製薬企業＆バイオ製薬企業における市場規模 ・世界の組換えタンパク質市場規模：地域別 - 南北アメリカの組換えタンパク質市場規模 アメリカの組換えタンパク質市場規模 カナダの組換えタンパク質市場規模 ブラジルの組換えタンパク質市場規模 ... - アジア太平洋の組換えタンパク質市場規模 日本の組換えタンパク質市場規模 中国の組換えタンパク質市場規模 インドの組換えタンパク質市場規模 韓国の組換えタンパク質市場規模 台湾の組換えタンパク質市場規模 ... -ヨーロッパ/中東/アフリカの組換えタンパク質市場規模 イギリスの組換えタンパク質市場規模 ドイツの組換えタンパク質市場規模 フランスの組換えタンパク質市場規模 ロシアの組換えタンパク質市場規模 ... -その他地域の組換えタンパク質市場規模 ・競争状況 ・企業情報 |
The Global Recombinant Proteins Market size was estimated at USD 3,892.78 million in 2021 and expected to reach USD 4,436.22 million in 2022, and is projected to grow at a CAGR 14.21% to reach USD 8,641.69 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Recombinant Proteins to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Adhesion Molecules and Receptors, Growth Factors and Chemokines, Immune Response Proteins, Kinase Proteins, Membrane Proteins, Other, Recombinant Metabolic Enzymes, Regulatory Proteins, and Structural Proteins.
Based on Application, the market was studied across Academic Research Studies, Biopharmaceutical Production, Biotechnology Research, Drug Discovery & Development, and Other.
Based on End User, the market was studied across Academic Research Institutes, Biotechnology Companies, Contract Research Organizations, Other, and Pharmaceutical & Biopharmaceutical Companies.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Recombinant Proteins market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Recombinant Proteins Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Recombinant Proteins Market, including Abcam plc, Abnova Corporation, ACROBiosystems, Bio-Rad Laboratories, Inc., BioLegend, Inc., BPS Bioscience, Inc., CellGenix GmbH, Enzo Life Sciences, Inc., GenScript Biotech Corporation, Merck KGaA, Miltenyi Biotech Inc., Neuromics, PeproTech, Inc., ProSpec-TechnoGene Ltd., Proteintech Group, Inc., R&D Systems, Inc., RayBiotech Inc, Sino Biological Inc., STEMCELL Technologies Inc., and Thermo Fisher Scientific, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Recombinant Proteins Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Recombinant Proteins Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Recombinant Proteins Market?
4. What is the competitive strategic window for opportunities in the Global Recombinant Proteins Market?
5. What are the technology trends and regulatory frameworks in the Global Recombinant Proteins Market?
6. What is the market share of the leading vendors in the Global Recombinant Proteins Market?
7. What modes and strategic moves are considered suitable for entering the Global Recombinant Proteins Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising focus on personalized medicine & protein therapeutics in the consumers
5.1.1.2. High prevalence of infectious & chronic diseases among geriatric population and children
5.1.1.3. Surging inclination of demand toward biologics and biosimilars proteins
5.1.2. Restraints
5.1.2.1. Declining cost of recombinant proteins and availability of alternative products
5.1.3. Opportunities
5.1.3.1. Increasing focus on biomarker discovery and surging rise of new ingredients
5.1.3.2. Rising investments and new product development in the recombinant protein market
5.1.3.3. Growing demand for recombinant protein in animal production
5.1.4. Challenges
5.1.4.1. Concerns regarding time consumption coupled with high costs and maintenance of recombinant protein
5.2. Cumulative Impact of COVID-19
6. Recombinant Proteins Market, by Product
6.1. Introduction
6.2. Adhesion Molecules and Receptors
6.3. Growth Factors and Chemokines
6.4. Immune Response Proteins
6.5. Kinase Proteins
6.6. Membrane Proteins
6.7. Other
6.8. Recombinant Metabolic Enzymes
6.9. Regulatory Proteins
6.10. Structural Proteins
7. Recombinant Proteins Market, by Application
7.1. Introduction
7.2. Academic Research Studies
7.3. Biopharmaceutical Production
7.4. Biotechnology Research
7.5. Drug Discovery & Development
7.6. Other
8. Recombinant Proteins Market, by End User
8.1. Introduction
8.2. Academic Research Institutes
8.3. Biotechnology Companies
8.4. Contract Research Organizations
8.5. Other
8.6. Pharmaceutical & Biopharmaceutical Companies
9. Americas Recombinant Proteins Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Recombinant Proteins Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Recombinant Proteins Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abcam plc
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Abnova Corporation
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. ACROBiosystems
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Bio-Rad Laboratories, Inc.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. BioLegend, Inc.
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. BPS Bioscience, Inc.
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. CellGenix GmbH
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Enzo Life Sciences, Inc.
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. GenScript Biotech Corporation
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Merck KGaA
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Miltenyi Biotech Inc.
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Neuromics
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. PeproTech, Inc.
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. ProSpec-TechnoGene Ltd.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Proteintech Group, Inc.
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. R&D Systems, Inc.
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. RayBiotech Inc
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Sino Biological Inc.
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. STEMCELL Technologies Inc.
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Thermo Fisher Scientific, Inc.
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing